P44 Phase 3 clinical trial results of a new combined oral contraceptive with estetrol 15 MG and drospirenone 3 MG

Authors
Publication date
17 February 2021
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Ezid

    redirect
    Last time updated on 08/04/2021